Eli Lilly and Company - PDFSEARCH.IO - Document Search Engine

Eli Lilly and Company
Results: 4186

#	Item
531	Drug Utilisation Sub-Committee Outcome Statement 7-8 February 2013 Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Organic chemistry Chemistry Pharmaceuticals policy Healthcare in Australia Pharmaceutical Benefits Scheme Health Quality use of medicines Antipsychotic Pioglitazone Pyridines Thiazolidinediones Eli Lilly and Company
532	Type 2 Diabetes review – ToR 4 COMPARATIVE SAFETY AND EFFECTIVENESS OF TYPE 2 DIABETES MEDICINES FINAL REPORT Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2014-10-09 02:50:10 Diabetes Anti-diabetic drugs Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Design of experiments Anti-diabetic medication Diabetes management Exenatide Metformin Chemistry Medicine Organic chemistry
533	Cisplatin Chemotherapy Information: Cisplatin Medication information leaflet for Add to Reading List Source URL: www.pics.org.au Language: English - Date: 2011-05-15 21:45:18 Cisplatin Cancer treatments Chemotherapy Eli Lilly and Company Carboplatin Gemcitabine Chemistry Alkylating antineoplastic agents Ammine complexes
534	BYETTA® (exenatide) Injection Add to Reading List Source URL: www.fda.gov Language: English Anorectics Exenatide Peptide hormones Pen needles Insulin Anti-diabetic medication Diabetes mellitus Hypoglycemia Kidney transplantation Medicine Anti-diabetic drugs Eli Lilly and Company
535	Table 11(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2006 to year end: JunYear ending Jun 2006 Rank Drug Year ending Jun 2007 Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Peptide hormones Recombinant proteins Merck Bisphosphonates Eli Lilly and Company Ezetimibe Rosuvastatin Statin Insulin glargine Chemistry Organic chemistry Biology
536	July 26, 2013 Revised Chemical List Add to Reading List Source URL: oehha.ca.gov Language: English - Date: 2014-03-18 01:07:24 Eli Lilly and Company Bisphenol A Bisphenols Dichloroacetic acid Phthalate Diethylstilbestrol Plasticizers Chemistry Medicine
537	Table 8: Top 3 drugs by generic name in ATC drug groups with greatest increase in Govt. cost (incl Drs bag), year ending: Jun 2006 to year ending: Jun 2007 JunChange from: Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Recombinant proteins Organic chemistry Beta blockers Alcohols Eli Lilly and Company Timolol Insulin glargine Brimonidine Insulin Chemistry Biology Peptide hormones
538	iMig2014 Cape Town Final Scientific Programme – 21-24 October 2014 DayOctober 2014 Welcome to Cape Town! Registration Welcome Cocktails 00.1 Add to Reading List Source URL: imig2014.org Language: English - Date: 2014-10-10 02:24:43 Occupational diseases Mesothelioma Raja M. Flores Eli Lilly and Company Sarcoma Pemetrexed Pneumonectomy Peritoneal mesothelioma Intraperitoneal hyperthermic chemoperfusion Medicine Oncology Asbestos
539	___________________ CONTRAINDICATIONS ___________________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing infor Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-12-16 11:25:05 Thrombocytosis Eli Lilly and Company Ketones Drug rehabilitation Polycythemia vera Hydroxycarbamide Essential thrombocytosis Methadone Plateletpheresis Medicine Chemistry Hematopathology
540	January[removed]Formulary Drug Removals Below is a list of medicines by drug class that have been removed from your plan’s formulary. This list is effective January 1, 2015. If you continue using one of the drugs listed Add to Reading List Source URL: drugchannelsinstitute.com Language: English - Date: 2014-08-04 11:01:31 Eli Lilly and Company Non-steroidal anti-inflammatory drugs Angiotensin II receptor antagonists Tetrazoles Amides Hydrochlorothiazide CVS Caremark OneTouch Ultra Diclofenac Chemistry Organic chemistry Pharmacology

UPDATE